权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Profiling the Fluid Assisted Dissemination of Pre-malignant cells in Fallopian Tubes

分析输卵管癌前细胞的液体辅助传播

基本信息

批准号：
10718158
负责人：
Geeta Mehta
金额：
$ 61.89万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-07-07 至 2028-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10718158
关键词：
3-Dimensional Abdominal Cavity Acceleration Affect Anatomy Animal Model BRCA1 gene Bioinformatics Biological Assay Biology Biophysical Process Bioreactors CDK4 gene Carcinoma Cell Culture Techniques Cell Death Cell Line Cells Collagen Complement Custom Cytoskeleton DNA Sequence Alteration Data Detection Development Disease Disease Progression Early Diagnosis Environment Epithelial Cells Epithelium Exposure to F-Actin Genes Genetic Genetic Variation Goals Greater sac of peritoneum Growth Harvest Human Immune Immune system Immunocompetent Immunocompromised Host Immunodeficient Mouse Immunologic Deficiency Syndromes Immunotherapy In Vitro Intraperitoneal Injections Invaded Lesion Link Liquid substance Location Malignant neoplasm of ovary Mammalian Oviducts Mechanics Microfluidic Microchips Microfluidics Modeling Molecular Molecular Profiling Movement Mus Mutate Mutation Neoplasm Metastasis Omentum Organ Ovarian Ovary Pathway interactions Patient-Focused Outcomes Patients Perfusion Peritoneal Peritoneum Pharmaceutical Preparations Play Polysaccharides Premalignant Cell Prevention Proliferating Proteomics Publishing RB1 gene Randomized Recurrent disease Regulation Research Role Scaffolding Protein Screening for Ovarian Cancer Secretory Cell Sepharose Serous Signal Pathway Signal Transduction Site Stage at Diagnosis Structure Surface Survival Rate TP53 gene Testing Tube Tumor Burden Validation Woman Work cancer cell cancer diagnosis cancer initiation cancer therapy cell growth clinical diagnosis clinical translation design and construction differential expression driver mutation early detection biomarkers effective therapy fluid flow gain of function genetic signature implantation improved in vivo in vivo Model intraperitoneal loss of function malignant breast neoplasm mechanical signal mechanical stimulus mechanotransduction migration mortality mouse model neoplastic cell novel screening shear stress sobriety statistics stem stemness subcutaneous trait transcriptome sequencing tumor tumor initiation tumor progression viscoelasticity

项目摘要

PROJECT SUMMARY The high mortality rate in ovarian cancers is explained in part, by late-stage clinical diagnosis where intraperitoneal tumor burden is already prevalent and widespread. Shedding and implantation of transformed secretory cells, originating from the fallopian tube, is considered one of the main initiators of ovarian cancer. During the early stages of this disease, secretory fallopian tube cells gain mutations that support migration (against the direction of fluid flow) to the ends of the fallopian tubes (fimbriae). At the fimbriae, the mutated fallopian tube cells form small early precursor lesions. Both the ovaries and fallopian tubes are suspended within the abdominal cavity, where the environment further exposes early precursor tumor cells to dynamic shear stresses. We therefore hypothesize that the fluidic shear stress stimulates the early precursor lesions in the fallopian tubes and modulates their dissemination to the ovary and peritoneal organs. In order to test this hypothesis, we will utilize microfluidic devices and bioreactors to circulate cell growth medium around transformed human and mouse fallopian tube cell lines that are supported on an agarose-collagen, polysaccharide-protein scaffold. Human immortalized fallopian tube cells with varying degrees of genetic mutation will be probed for changes in cell replication, migration, invasion, cell death, and genetic variation after stimulation of shear stress. Our preliminary data suggests a robust increase in the expression of GPRC5A in fallopian tube secretory epithelial cells (FTSEC) under shear stress stimulation. Therefore, we will validate this discovery in FTSEC cell lines with driver mutations and patient-derived cells, and investigate the GPRC5A molecular pathway and its components that are activated in FTSEC under shear stress stimulation, by utilizing gain-of-function and loss-of-function assays. Shear stressed and static control mutated fallopian tube cells will be tested for stemness and the capacity to initiate tumors in immunodeficient mice. Stimulated transformed fallopian tube cells will also be injected into immunocompromised mice to investigate the cell’s ability to colonize and form tumors. These studies will also be performed in mice with intact immune systems in order to assess whether immune cells impact growth and dissemination. Given that no published studies have yet identified the role of shear stresses in dissemination of early precursor lesions in ovarian cancers, the proposed work can potentially have much broader impact. For example, with our dynamic microfluidic and 3D bioreactor models, mechanotransduction and immunotherapy drugs can be screened for development of effective cancer therapies. The components of the shear stress-induced mechanotransduction that are identified in our proposed work, could also be utilized in early detection of ovarian cancers. As a result, the important role of shear stresses in the fluidic niches of ovarian cancers will be established. Lastly, our study on the mechanical regulation of transformed epithelial cells will be highly relevant to fundamental biology and clinical translational alike.

项目总结